GlassScriptPhysician profile
Claire Hooker
NPI 1386463552
$951.84
in general payments reported to CMS, 2019-2025
15 companies · $952 in 2025
The $952 reported for 2025 was more than what 82% of Physician Assistant providers received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2025: $952.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $952.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $951.84 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $195.61 | 2025 | Ozempic, Rybelsus, Wegovy |
| Exact Sciences Corporation | $134.55 | 2025 | The Cologuard Plus Collection Kit, Cologuard Collection Kit |
| Gilead Sciences, INC. | $107.03 | 2025 | |
| Lilly USA, LLC | $91.22 | 2025 | Mounjaro, Kisunla, Zepbound |
| Lundbeck LLC | $74.62 | 2025 | Vyepti, Rexulti |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $62.50 | 2025 | Xifaxan |
| Abbvie INC. | $47.47 | 2025 | |
| Edwards Lifesciences Corporation | $35.98 | 2025 | Edwards Sapien 3 Ultra Transcatheter Heart Valve |
| Merck Sharp & Dohme LLC | $35.80 | 2025 | Varivax, Capvaxive, Vaqta |
| Currax Pharmaceuticals LLC | $33.29 | 2025 | Contrave |
| Invivyd INC | $32.53 | 2025 | Pemgarda |
| Viiv Healthcare Company | $30.82 | 2025 | Apretude |
| Axsome Therapeutics, INC. | $27.95 | 2025 | Symbravo |
| Hologic Sales and Service, LLC | $22.28 | 2025 | Aptima |
| Pfizer INC. | $20.19 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Claire Hooker listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.